Prof. Dr. A (Ton) Hagenbeek (1948 – 2021)
17 May 2021
Professor of Hematology, Academic Medical Center (AMC) , Dept. of Hematology , University of Amsterdam.
Today, the international community has lost a true leader in the field of hematology. Prof. Hagenbeek has touched and inspired many doctors and scientists in carrying out the best cancer care and research for patients. His boundless enthusiasm and commitment have helped many organisations to drive new innovations in cancer care.
It is with great sadness that we learn the death of Professor Hagenbeek. EORTC has lost a major contributor to its scientific agenda and a peer. Professor Hagenbeek has been leading many EORTC studies in the field of lymphoma research which have made a difference for patients, as well as acting as a true leader for the EORTC Lymphoma group. His vision and dedication to hematology, collaborating across the world, positioned him as a pioneer in clinical research already in the years 80s.
We will remember Professor Hagenbeek as a generous, passionate and talented scientist, doctor and clinical investigator, always going the extra mile, pushing relentlessly the boundaries of therapeutic progress for cancer patients.
Related News
First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer
28 Oct 2026
EORTC at ESMO 2026: New findings and ongoing studies
27 Oct 2026
EORTC research presented at ESMO 2026
22 Oct 2026
EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
